Inceptor Bio announces $37M in Series A funding

Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, today announced the closing of a $37 million Series A financing led by Kineticos Ventures.

They have big goals for this funding, including their plans to:

  • Advance their CAR-T lead program to a Phase I clinical trial
  • Continue development of CAR-M
  • Continue development of CAR-NK
  • Complete construction of their Advanced Manufacturing Platform (AMP+) facility – a state-of-the-art cell and gene therapy GMP manufacturing site –  in Gainesville, Florida.

Inceptor Bio’s CAR-T, CAR-M, and CAR-NK platforms are the center of their diversified portfolio of cell therapies. These therapies are focused on novel mechanisms to enhance cell performance in the tumor microenvironment. Novel technologies include a co-stimulatory domain M83, proprietary TMax manufacturing process, the K62 platform, which increases the phagocytic capabilities of macrophages and supports a M1 anti-tumor phenotype, and a differentiated iPSC technology.

Advancing thest technologies will require the expansion of their team as they work to onboard additional scientists and engineers to improve treatment options.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at or contact your usual Swanson Reed representative.

Recent Posts